Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 10, 2019

SELL
$1.1 - $1.74 $181,259 - $286,718
-164,781 Closed
0 $0
Q4 2018

Jan 31, 2019

BUY
$1.0 - $6.12 $164,781 - $1.01 Million
164,781 New
164,781 $178,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $54.2M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.